S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$302.00
+0.2%
$312.73
$176.34
$413.20
$22.73B1.65739,761 shs62,564 shs
Coloplast A/S stock logo
CLPBY
Coloplast A/S
$12.87
-0.7%
$13.38
$9.90
$14.77
N/A-0.0437,274 shs51,657 shs
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$86.30
-0.2%
$90.14
$60.57
$96.12
$51.95B1.053.82 million shs428,561 shs
STERIS plc stock logo
STE
STERIS
$198.75
-1.0%
$224.20
$180.54
$254.00
$19.64B0.79457,263 shs59,110 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$119.24
-0.1%
$126.39
$102.00
$149.25
$24.50B1.011.47 million shs179,002 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+0.40%-7.25%-5.00%+13.14%-15.44%
Coloplast A/S stock logo
CLPBY
Coloplast A/S
-0.69%-5.02%-4.45%+12.11%-6.69%
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
-0.91%-5.43%-8.27%+16.34%-0.06%
STERIS plc stock logo
STE
STERIS
+0.23%-2.65%-12.79%-9.36%+7.48%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
-1.56%-6.37%-5.73%-3.21%-13.55%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Align Technology, Inc. stock logo
ALGN
Align Technology
4.7477 of 5 stars
3.24.00.03.82.02.53.1
Coloplast A/S stock logo
CLPBY
Coloplast A/S
N/AN/AN/AN/AN/AN/AN/AN/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
4.4101 of 5 stars
2.34.00.04.03.22.52.5
STERIS plc stock logo
STE
STERIS
4.5008 of 5 stars
2.32.04.23.82.61.72.5
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.7195 of 5 stars
3.13.01.73.72.72.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.44
Hold$344.4514.06% Upside
Coloplast A/S stock logo
CLPBY
Coloplast A/S
2.00
HoldN/AN/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
2.53
Moderate Buy$91.736.30% Upside
STERIS plc stock logo
STE
STERIS
2.50
Moderate Buy$239.6020.55% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.27
Hold$139.3916.90% Upside

Current Analyst Ratings

Latest EW, ALGN, ZBH, CLPBY, and STE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$350.00 ➝ $400.00
4/15/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$280.00 ➝ $320.00
4/15/2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$95.00 ➝ $101.00
4/12/2024
STERIS plc stock logo
STE
STERIS
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/11/2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$95.00 ➝ $105.00
4/4/2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$86.00 ➝ $92.00
4/4/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$125.00 ➝ $130.00
4/3/2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$90.00 ➝ $98.00
4/3/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$134.00 ➝ $140.00
3/26/2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMixed ➝ Positive
3/21/2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$95.00 ➝ $103.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$3.86B5.88$8.51 per share35.50$47.40 per share6.37
Coloplast A/S stock logo
CLPBY
Coloplast A/S
$3.58BN/A$0.43 per share30.18N/AN/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$6.00B8.65$2.73 per share31.57$11.08 per share7.79
STERIS plc stock logo
STE
STERIS
$4.96B3.96$18.73 per share10.61$61.31 per share3.24
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.39B3.31$11.92 per share10.00$59.76 per share2.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$445.05M$5.8251.8933.745.3711.52%13.88%8.26%4/24/2024 (Confirmed)
Coloplast A/S stock logo
CLPBY
Coloplast A/S
$685.88M$0.3339.0031.393.0419.48%43.30%11.89%N/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$1.40B$2.3037.5227.844.3223.35%23.56%16.81%4/25/2024 (Confirmed)
STERIS plc stock logo
STE
STERIS
$107.03M$5.7134.8120.88N/A10.48%13.67%7.68%5/8/2024 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.02B$4.8924.3813.692.2313.85%12.79%7.43%5/2/2024 (Confirmed)

Latest EW, ALGN, ZBH, CLPBY, and STE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.88N/A-$1.88N/AN/AN/A  
4/25/2024N/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.64N/A-$0.64N/AN/AN/A  
4/24/2024N/A
Align Technology, Inc. stock logo
ALGN
Align Technology
$1.9750N/A-$1.9750N/AN/AN/A  
2/9/202412/31/2023
Coloplast A/S stock logo
CLPBY
Coloplast A/S
$0.08$0.08N/A$0.08N/A$953.60 million
2/8/2024Q4 2023
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$2.15$2.20+$0.05$2.39$1.93 billion$1.94 billion    
2/7/2024Q3 24
STERIS plc stock logo
STE
STERIS
$2.17$2.22+$0.05$3.02$1.35 billion$1.40 billion    
2/6/2024Q4 23
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.64$0.64N/A$0.67$1.50 billion$1.53 billion    
1/31/2024Q4 2023
Align Technology, Inc. stock logo
ALGN
Align Technology
$1.78$1.91+$0.13$2.18$928.57 million$956.73 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Coloplast A/S stock logo
CLPBY
Coloplast A/S
N/AN/AN/AN/AN/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
STERIS plc stock logo
STE
STERIS
$2.081.05%+8.74%36.43%19 Years
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.81%N/A19.63%N/A

Latest EW, ALGN, ZBH, CLPBY, and STE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.77%3/27/20243/29/20244/30/2024
1/30/2024
STERIS plc stock logo
STE
STERIS
Quarterly$0.520.95%2/22/20242/23/20243/22/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.18
1.04
Coloplast A/S stock logo
CLPBY
Coloplast A/S
0.76
0.53
0.35
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.09
3.38
2.40
STERIS plc stock logo
STE
STERIS
0.50
2.43
1.49
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.39
1.61
0.78

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Coloplast A/S stock logo
CLPBY
Coloplast A/S
N/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
79.46%
STERIS plc stock logo
STE
STERIS
94.69%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.64%
Coloplast A/S stock logo
CLPBY
Coloplast A/S
N/A
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
1.29%
STERIS plc stock logo
STE
STERIS
0.95%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.95%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
21,61075.25 million74.77 millionOptionable
Coloplast A/S stock logo
CLPBY
Coloplast A/S
15,913N/AN/ANot Optionable
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
19,800601.93 million594.16 millionOptionable
STERIS plc stock logo
STE
STERIS
17,10098.81 million97.88 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000205.46 million203.51 millionOptionable

EW, ALGN, ZBH, CLPBY, and STE Headlines

SourceHeadline
Sumitomo Mitsui Trust Holdings Inc. Sells 52,239 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Sumitomo Mitsui Trust Holdings Inc. Sells 52,239 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 19 at 5:29 AM
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by Calamos Advisors LLCZimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by Calamos Advisors LLC
marketbeat.com - April 18 at 5:02 PM
Oak Family Advisors LLC Takes $7.87 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Oak Family Advisors LLC Takes $7.87 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 15 at 3:32 PM
International Assets Investment Management LLC Purchases 66,345 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)International Assets Investment Management LLC Purchases 66,345 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 14 at 4:50 AM
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Live Oak Private Wealth LLCZimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Live Oak Private Wealth LLC
marketbeat.com - April 12 at 10:16 PM
GW Henssler & Associates Ltd. Sells 14,098 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)GW Henssler & Associates Ltd. Sells 14,098 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 10 at 6:43 PM
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-TermWhy Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
zacks.com - April 10 at 10:41 AM
The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look PromisingThe Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
finance.yahoo.com - April 10 at 10:25 AM
Sequoia Financial Advisors LLC Acquires 42,539 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Sequoia Financial Advisors LLC Acquires 42,539 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 9 at 12:59 PM
Allspring Global Investments Holdings LLC Increases Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Allspring Global Investments Holdings LLC Increases Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 8 at 8:42 PM
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Ceredex Value Advisors LLCZimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Ceredex Value Advisors LLC
marketbeat.com - April 7 at 3:55 PM
DAVENPORT & Co LLC Acquires 10,166 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)DAVENPORT & Co LLC Acquires 10,166 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 6 at 5:32 AM
Matrix Asset Advisors Inc. NY Acquires 21,459 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Matrix Asset Advisors Inc. NY Acquires 21,459 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 5 at 8:39 PM
Zimmer Biomet Becomes First Medical Device Partner For Three Pickleball Organizations In United StatesZimmer Biomet Becomes First Medical Device Partner For Three Pickleball Organizations In United States
inkfreenews.com - April 5 at 7:07 PM
Q1 2026 Earnings Forecast for Zimmer Biomet Holdings, Inc. Issued By Zacks Research (NYSE:ZBH)Q1 2026 Earnings Forecast for Zimmer Biomet Holdings, Inc. Issued By Zacks Research (NYSE:ZBH)
marketbeat.com - April 5 at 9:09 AM
Evercore ISI Boosts Zimmer Biomet (NYSE:ZBH) Price Target to $130.00Evercore ISI Boosts Zimmer Biomet (NYSE:ZBH) Price Target to $130.00
marketbeat.com - April 4 at 1:51 PM
Zimmer Biomet Becomes First and Only Official Medical Device Partner of Association of Pickleball Players, Professional Pickleball Association, and USA PickleballZimmer Biomet Becomes First and Only Official Medical Device Partner of Association of Pickleball Players, Professional Pickleball Association, and USA Pickleball
finance.yahoo.com - April 4 at 10:36 AM
Zacks Research Brokers Reduce Earnings Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Zacks Research Brokers Reduce Earnings Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 4 at 8:32 AM
What 6 execs at Zimmer Biomet were paid over 3 yearsWhat 6 execs at Zimmer Biomet were paid over 3 years
beckersspine.com - April 3 at 1:55 PM
Unveiling 7 Analyst Insights On Zimmer Biomet HoldingsUnveiling 7 Analyst Insights On Zimmer Biomet Holdings
markets.businessinsider.com - April 3 at 1:55 PM
Citigroup Raises Zimmer Biomet (NYSE:ZBH) Price Target to $140.00Citigroup Raises Zimmer Biomet (NYSE:ZBH) Price Target to $140.00
marketbeat.com - April 3 at 12:14 PM
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2024 Financial ResultsZimmer Biomet Announces Webcast and Conference Call of First Quarter 2024 Financial Results
finance.yahoo.com - April 3 at 8:55 AM
Raymond James & Associates Sells 93,401 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Raymond James & Associates Sells 93,401 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
marketbeat.com - April 3 at 4:27 AM
5 Medical Product Stocks to Buy Amid Industry Challenges5 Medical Product Stocks to Buy Amid Industry Challenges
zacks.com - April 2 at 9:37 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Align Technology logo

Align Technology

NASDAQ:ALGN
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
Coloplast A/S logo

Coloplast A/S

OTCMKTS:CLPBY
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Edwards Lifesciences logo

Edwards Lifesciences

NYSE:EW
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
STERIS logo

STERIS

NYSE:STE
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Zimmer Biomet logo

Zimmer Biomet

NYSE:ZBH
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.